SCHEMBL10089986

SCHEMBL10089986

Cc1c(F)ccc(C(=O)NCc2ccccc2Cl)c1NC(=O)c1cc(Cn2nnc(C(F)(F)F)n2)nn1-c1ncccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 3/20 0.39
TP53 P04637 1/20 0.38
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
NR3C1 P04150 1/20 0.35
P2RX7 Q99572 1/20 0.35
MAPT P10636 1/20 0.35
CNR2 P34972 1/20 0.34
NTRK1 P04629 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 2/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10089905 0.93 HSD17B13 (0.39) MAPK8
SCHEMBL15905592 0.92 DHODH (0.37) CNR2NTRK1PPARG
SCHEMBL17122545 0.92 MAPK8 (0.38) MAPK8TP53KMT2AMEN1NR3C1
SCHEMBL10089841 0.91 TP53 (0.38) MAPK8TP53KMT2AMEN1NR3C1
SCHEMBL10089882 0.91 MMP13 (0.38) KMT2AMEN1CNR2NTRK1HPGD
SCHEMBL10090038 0.90 PPARG (0.35) NTRK1PPARG
SCHEMBL10089873 0.90 MAPK8 (0.36) MAPK8TP53P2RX7NTRK1GAA
SCHEMBL10090033 0.89 PDE2A (0.35) KDM4EALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL10089948 0.88 TP53 (0.35) MAPK8TP53KMT2AMEN1NR3C1
SCHEMBL10089982 0.88 PPARG (0.39) PPARGROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791143-B2 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains DDT, ADCY1, ANTXR2 MAPK8 4028/4885TP53 3397/4885KMT2A 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.